In Reply

Adjuvant Therapy for Women Over Age 65 With Breast Cancer by Prof. Dr. med. Marie-Luise Sautter-Bihl, Prof. Dr. med. Rainer Souchon, Prof. Dr. med. Bernd Gerber in volume 21/2011

We thank Wenderlein for the additional study data and the repeated emphasis on the necessity—which we also noted in our article—of defining an indication on an individual case basis considering biological age and by using the appropriate standardized scores (see Table 4 and reference list items e9, e10, 11).

DOI: 10.3238/arztebl.2012.0068b

Prof. Dr. med. Marie-Luise Sautter-Bihl

Klinik für Radioonkologie und Strahlentherapie

Städtisches Klinikum Karlsruhe

Conflict of interest statement
The author declares that no conflict of interest exists

References

1. Sautter-Bihl ML, Souchon R, Gerber B: Adjuvant therapy for women over age 65 with breast cancer. Dtsch Arztebl Int 2011; 108(21): 365–71.